A 4 week, open label clinical trial for the evaluation of the efficacy and safety of S-light program on reducing body weight and body fat of overweight females.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000932

Enrollment

Registered

2013-11-19

Start date

2013-11-07

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Every subject take investigation products(4 kinds) as a aomunt of intake and method of intake per day. -investigation products 1(AP-FC): once a day, morning -investigation produc

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Female subjects between 20-65years of age inclusive. 2) BMI of 26.0-29.9kg/m2 3) Evidense of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the trial.

Exclusion criteria

Exclusion criteria: 1. Subjects with systolic BP 160> or diastolic BP 100>mmHg 2. Subjects with diabetes(use of hypoglycemic agent or insulin)or fasting blood glucose 126= or random blood glucose =200 3. Subjects with severe cerebrovascular disease(infarct, hemorrage), cardiac disease(angina, myocardiac infarct, heart failure, arrhythmias that require treatment) within recent 6 months. (If that patient's clinical status is stable, they can participate in the clinical trial according to the investgator) 4.Subjects with gastrointestinal hemorrhage according to clinical examination of the investgator. 5. Subjets with a history of cancer and inetrvention within the 5 years prior to screening. 6. Use of prescription drugs or supplements known to alter body weight or appetite, antidepressants, oral contraceptive, steroid, female sex hormon within the 1 months prior to screenin. 7. Participation in any diet program within the 3 months prior to screening. 8. Subjects with endocrinopathy or abnormal screening TSH value(=0.1uU/ml or =10uU/ml) 9. Serum creatinine = 2times the the upper limit of normal 10. Serum AST/ALT = 2times the the upper limit of normal 11. Subjects with a history of CNS disorder(depressivedisorder,schizophrenia, alcoholism, drug addiction ) 12. Subjects with the musculoskeletal system disorder or restricted physical activity 13. Woman who are pregnant or lactating. 14. Subjects with in the soybean allergy. 15. Subjects which in the opinion investigator could affect preclude evauation of response.

Design outcomes

Primary

Measure	Time frame
body weight, fat mass, fat percentage, BMI	—

Secondary

Measure	Time frame
veceral fat;waist circumference, hip circumference, WHR	—

Countries

Korea, Republic of

Contacts

Public ContactIN SUN JEONG

Inje University Seoul Paik Hospital

Outcome results